Revolutionary eye camera could catch blindness early

NCT ID NCT03963817

Ongoing Diagnosis Sponsor: Icahn School of Medicine at Mount Sinai Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new, ultra-high-resolution eye scanner that combines two imaging techniques to see the retina in 3D. Researchers will scan 10 healthy adults and 40 people with early or intermediate age-related macular degeneration (AMD). The goal is to improve early detection of AMD, which could help slow vision loss with timely care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: adaptive optics AO-OCT/AF instrument
What this could lead to: If successful, this imaging method could help doctors detect AMD earlier and track its progression more accurately, potentially slowing vision loss through timely treatment.
What could go wrong: This is a small, early-stage study focused on imaging, not treatment. The technology may not prove reliable enough for widespread use, and results may not apply to all AMD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

age-related macular degeneration macular degeneration

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AGE-RELATED MACULAR DEGENERATION

Contacts and locations

Locations

New York Eye and Ear Infirmary of Mount Sinai

New York, New York, 10003, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.